Demographics/BL Characteristics
Mean (SD) unless specifiedSEC300 mg SC(N = 167)SEC150 mg SC(N = 165)PBO(N = 166)
Age (yrs) 46.2 (12.3)46.9 (11.5) 46.6 (11.5)
Male, n (%) 77 (46.1) 81 (49.1) 88 (53.0)
Evidence of current psoriasis, n (%) 152 (91.0)147 (89.1)153 (92.2)
Time since first axial symptoms (yrs) 6.8 (7.7)7.4 (7.6)7.7 (9.5)
Total back pain score, VAS 72.5 (13.8)73.6 (15.3) 74.0 (13.7)
Inflammatory back pain parameters, n (%)
Onset of back pain is insidious 150 (89.8) 147 (89.1) 152 (91.6)
Back pain improving with exercise 148 (88.6) 139 (84.2) 146 (88.0)
Back pain worsening with rest 152 (91.0) 151 (91.5) 157 (94.6)
Night pain with improvement upon getting up 147 (88.0) 147 (89.1) 143 (86.1)
Awakening due to back pain in 2nd half of night 143 (85.6) 145 (87.9) 137 (82.5)
Alternating buttock pain 102 (61.1) 98 (59.4) 101 (60.8)
Back pain improved after NSAID intake in past 136 (81.4) 134 (81.2) 138 (83.1)
BASDAI 7.3 (1.2) 7.2 (1.4) 7.3 (1.2)
HLA-B27 positive, n/M (%) 31/85 (36.5)24/82 (29.3)26/74 (35.1)